Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04871490 · ClinicalTrials.gov registry record · NA
Improving Detection and Early Action for HPV-positive Oropharynx Cancer
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04871490 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 40 participants.
The verdict
NCT04871490, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study aims to determine whether a blood test for HPV DNA can improve diagnosis of HPV-positive oropharynx cancer (HPV-OPC).
Interventions
- DIAGNOSTIC_TEST Blood test for HPV DNA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-03-24 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04871490
The ClinicalTrials.gov registry entry for NCT04871490 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood test for HPV DNA is the first listed.
NCT04871490 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04871490 about?
NCT04871490 is a clinical study titled "Improving Detection and Early Action for HPV-positive Oropharynx Cancer". This study aims to determine whether a blood test for HPV DNA can improve diagnosis of HPV-positive oropharynx cancer (HPV-OPC).
What is the current status of trial NCT04871490?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-03-24. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT04871490?
The interventions under investigation include: Blood test for HPV DNA (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04871490?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.